Graybug Vision, Inc.
NASDAQ: GRAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Frederic Guerard
- Employees
- 8
- Headquarters
- Redwood City, United States
- IPO year
- 2020
- Market cap
- $121.0M
- Website
- https://www.graybug.vision
Loading GRAY…
Loading profile data…Frequently asked questions about GRAY
What does Graybug Vision, Inc. (GRAY) do?
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing thr...
Where does GRAY trade?
Graybug Vision, Inc. (GRAY) trades on the NASDAQ Global Market.
What sector is GRAY in?
Graybug Vision, Inc. (GRAY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Graybug Vision, Inc.?
Frederic Guerard is the chief executive officer of Graybug Vision, Inc. (GRAY).
Where is Graybug Vision, Inc. headquartered?
Graybug Vision, Inc. is headquartered in United States.
Does GRAY pay a dividend?
Graybug Vision, Inc. (GRAY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GRAY go public?
Graybug Vision, Inc. (GRAY) completed its initial public offering in 2020.